EBS Financial Facts

Cost of product sales: 39.56M
Other income (expense), net: -234K
See Full Income Statement

Accrued compensation: 32.1M
Retained earnings: 214.69M
See Full Balance Sheet

Emergent BioSolutions, Inc. (EBS) Earnings

  |   Expand Research on EBS
Next EPS Date 10/29/26 *Est. EPS Growth Rate +275.0% *Last Qtr.
Average EPS % Beat Rate +104.2% Revenue Growth Rate +66.3% *Last Qtr.
Average % Move 1-Wk after EPS -6.0% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/5/26 Q226 $0.60$0.11 +$0.49$234.3M$186M N/A Details
4/30/26 Q126 $0.21$0.86 -$0.65$156.1M$205M N/A Details
2/26/26 Q425 -$0.43$0.38 -$0.81$148.7M$237M N/A Details
10/29/25 Q325 N/A$0.05 N/A $231.1M$203.67M N/A N/A N/A
8/6/25 Q225 $0.16-$0.10 +$0.26$140.9M$174M N/A Details
5/7/25 Q125 $0.71$0.49 +$0.22$222.2M$279M N/A Details
4/24/25 Q125 N/A$0.49 N/A N/A$279M N/A N/A N/A
2/20/25 Q424 N/A-$0.41 N/A N/A$243.33M = N/A N/A